Igc Pharma Inc
(IGC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,786 | -1,211 | -679 | -433 | -1,853 |
| Depreciation Amortization | 19 | 15 | 10 | 6 | 396 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 19 |
| Accounts receivable | -34 | -402 | -281 | -87 | -145 |
| Accounts payable and accrued liabilities | N/A | 34 | 197 | 11 | 191 |
| Other Working Capital | -754 | -319 | -333 | -439 | 10 |
| Other Operating Activity | 624 | 910 | 459 | 419 | -10 |
| Operating Cash Flow | $-1,931 | $-973 | $-627 | $-522 | $-1,391 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -4 | N/A | N/A | -96 |
| PPE Investments | -136 | -11 | -9 | -4 | -146 |
| Sale Of Investment | N/A | N/A | -2 | N/A | N/A |
| Purchase Sale Intangibles | -65 | -286 | -137 | 0 | N/A |
| Other Investing Activity | -521 | -286 | -137 | 0 | 0 |
| Investing Cash Flow | $-657 | $-301 | $-148 | $-4 | $-241 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 679 |
| Debt Repayment | 35 | N/A | -94 | -280 | -476 |
| Common Stock Issued | 3,489 | 2,525 | 938 | 613 | 642 |
| Other Financing Activity | 191 | -107 | 0 | 0 | -137 |
| Financing Cash Flow | $3,715 | $2,418 | $844 | $333 | $708 |
| Exchange Rate Effect | -7 | 9 | -10 | 0 | -28 |
| Beginning Cash Position | 538 | 538 | 538 | 538 | 1,491 |
| End Cash Position | 1,658 | 1,691 | 597 | 346 | 538 |
| Net Cash Flow | $1,120 | $1,153 | $59 | $-192 | $-953 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,931 | -973 | -627 | -522 | -1,391 |
| Capital Expenditure | -136 | -11 | -9 | -4 | -146 |
| Free Cash Flow | -2,067 | -984 | -636 | -526 | -1,537 |